Our efforts regarding the research and development of new products are driven by our mission and values. We aim to provide quality, lifesaving products to patients in need and to remove barriers to accessing quality care. In order to do this, we intentionally manage our portfolio of products to fill unique niches in the market in order to sustain our priority work of serving small patient populations.
In the coming years, we aim to develop more products designated with the Humanitarian Device Exemption. An example of our commitment to HDEs is the Flourish Pediatric Esophageal Atresia Device. Flourish was created to give doctors a minimally invasive alternative to surgery when treating esophageal atresia – a congenital birth defect which occurs in about 1 in every 2,500 newborns¹. Esophageal atresia is a birth defect of the esophagus – the tubular structure that connects the mouth to the stomach. In babies born with this condition, the upper part of the esophagus does not connect to the lower part of the esophagus and the stomach, making it impossible for them to eat normally. Using rare earth magnets, Flourish gradually stretches both ends of the infant’s esophageal pouches together to form a fully functioning esophagus. This is a life-changing procedure that provides an alternative to an invasive procedure with an extended recovery period.